<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Human parvovirus B 19 is known as a virus causing <z:hpo ids='HP_0010783'>erythema</z:hpo> infectiosum, <z:hpo ids='HP_0003040'>arthropathy</z:hpo>, transient aplastic crisis and intrauterine fetal <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Healthy hosts are able to clear the virus within weeks after <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>There are a few reports available in the literature regarding immunocompromised renal transplant recipients with <z:e sem="disease" ids="C1264606" disease_type="Disease or Syndrome" abbrv="">persistent infection</z:e> without seroconversion </plain></SENT>
<SENT sid="3" pm="."><plain>Herein, we describe a 56-year old woman with a relapse of grade II follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> who received a combined immunochemotherapy of rituximab, fludarabine and <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and subsequently developed a persistent <z:e sem="disease" ids="C0085273" disease_type="Disease or Syndrome" abbrv="">parvovirus B19 infection</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In the absence of serum immunoglobulin antibodies, PCR analysis of peripheral blood and bone marrow aspirate were positive for parvovirus B19 </plain></SENT>
<SENT sid="5" pm="."><plain>Treatment with IVIG treatment resulted in normalization of peripheral blood counts within 7 weeks </plain></SENT>
</text></document>